X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.410
+0.450 (11.36%)
At close: Jul 10, 2026, 4:00 PM EDT
4.400
-0.010 (-0.23%)
After-hours: Jul 10, 2026, 4:58 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $415.95 million as of July 10, 2026. Its market cap has increased by 3,305.48% in one year.
Market Cap
415.95M
Enterprise Value
247.22M
1-Year Change
3,305.48%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $415.95M, an increase of 308.70%. That is a compound annual growth rate of 21.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 415.95M | 18.93% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 402.11M |
| Lexeo Therapeutics | 396.53M |
| Atea Pharmaceuticals | 392.93M |
| Vanda Pharmaceuticals | 383.66M |
| Vicore Pharma Holding AB | 374.17M |
| Fate Therapeutics | 362.50M |
| Fennec Pharmaceuticals | 358.14M |
| Lyell Immunopharma | 354.91M |